• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TANDEM DIABETES CARE T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY; AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TANDEM DIABETES CARE T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY; AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND Back to Search Results
Model Number 1002717
Device Problem Insufficient Flow or Under Infusion (2182)
Patient Problems Hyperglycemia (1905); Diabetic Ketoacidosis (2364); Coma (2417)
Event Date 07/01/2020
Event Type  Injury  
Manufacturer Narrative
No product was returned for evaluation.Should new relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that the customer experienced a blood glucose (bg) level of approximately 600 mg/dl, which was addressed via bolus with pump.However, customer was subsequently hospitalized due to diabetic ketoacidosis, resulting in a diabetic coma.Treatment was administered via intravenous insulin.Reportedly, the customer was released three days later with the issue resolved and no permanent damage.The customer alleged that the pump was not delivering insulin properly; however this could not be confirmed as customer declined a system check with tandem technical support.Customer reverted to manual injections for insulin delivery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY
Type of Device
AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND
Manufacturer (Section D)
TANDEM DIABETES CARE
11075 roselle street
san diego CA 92121
MDR Report Key10848043
MDR Text Key216554016
Report Number3013756811-2020-126611
Device Sequence Number1
Product Code OZO
UDI-Device Identifier00850006613380
UDI-Public00850006613380
Combination Product (y/n)N
PMA/PMN Number
K201214
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 11/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number1002717
Device Catalogue Number1005706
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/17/2021
Was the Report Sent to FDA? Yes
Date Manufacturer Received04/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
INSULIN TYPE: HUMALOG; INSULIN TYPE: HUMALOG
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age57 YR
-
-